![Petter Lindqvist](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Petter Segelman Lindqvist is currently the Chief Executive Officer at Isofol Medical AB. He previously served as the Chief Executive Officer at Hamlet BioPharma AB. Mr. Lindqvist is a graduate of Stockholm School of Economics.
| Bedrijven | Functie | Begin |
|---|---|---|
| ISOFOL MEDICAL AB | Algemeen Directeur | 09-01-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
| HAMLET PHARMA AB (PUBL) | Algemeen Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 3 |
|---|---|
Stockholm School of Economics
 Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Isofol Medical AB
 Isofol Medical AB Pharmaceuticals: MajorHealth Technology Provides novel folate-based pharmaceutical products | Health Technology |
Hamlet BioPharma AB
 Hamlet BioPharma AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products specifically for cancer patients | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
